Australian-based SUDA has entered into a definitive agreement to buy NovaDel Pharma's NovaMist technology and certain other assets. The transaction, as contemplated, does not include intellectual property or licenses of NovaDel's ...
Tags: SUDA, Novadel Pharma Novamist
NovaDel Pharma has signed a preliminary agreement to sell its NovaMist technology to SUDA, Australia-based pharmaceutical company. The acquisition, which includes the sale of NovaDel's patents and trademarks relating to NovaMist ...
Tags: NovaDel Pharma, acquisition, commercial terms, SUDA